Hudson Bay Capital Management
NRXP icon

Hudson Bay Capital Management’s NRX Pharmaceuticals NRXP Stock Holding History

Hudson Bay Capital Management’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-37,500
Closed -$3.94M – 460
2019
Q2 		$3.94M Buy
+37,500
New +$3.9M 0.09% 207

Other funds holding NRXP

OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Hudson Bay Capital Management's NRXP Position: Q3 2019 in Review

Hudson Bay Capital Management sold out of NRX Pharmaceuticals (NRXP) in Q3 2019, closing a stake of 37,500 shares — an estimated $3.94M sold.

Hudson Bay Capital Management first reported a position in NRXP in Q2 2019 and held it in 1 quarter. The position peaked at $3.94M in Q2 2019. 15 funds tracked by Wall St. Rank hold NRXP as of Q3 2019.

  • Hudson Bay Capital Management reported no remaining NRX Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Hudson Bay Capital Management sold 37,500 NRX Pharmaceuticals shares in Q3 2019, an estimated $3.94M.
  • Hudson Bay Capital Management first reported a position in NRX Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Hudson Bay Capital Management's NRX Pharmaceuticals position peaked at $3.94M in Q2 2019.
  • 15 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2019.

Based on Hudson Bay Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.